drd5

Migration, Crosslink

📖

drd5

active

wiki page Created: 2026-04-02T07:19:21 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-drd5

📖 Wiki Page

gene1730 wordssynced 2026-04-02

drd5

<div class="infobox infobox-gene">
<div class="infobox-header">DRD5 — Dopamine Receptor D5</div>

<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">DRD5</span></div>
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Dopamine Receptor D5</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">4p15.1</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[1816](https://www.ncbi.nlm.nih.gov/gene/1816)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl ID</span><span class="infobox-value">ENSG00000169679</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[P21918](https://www.uniprot.org/uniprot/P21918)</span></div>
<div class="infobox-row"><span class="infobox-label">Receptor Class</span><span class="infobox-value">D1-like (Gs-coupled)</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">Hippocampus, Prefrontal cortex, Striatum, Thalamus</span></div>
</div>

Introduction

...

drd5

<div class="infobox infobox-gene">
<div class="infobox-header">DRD5 — Dopamine Receptor D5</div>

<div class="infobox-row"><span class="infobox-label">Symbol</span><span class="infobox-value">DRD5</span></div>
<div class="infobox-row"><span class="infobox-label">Full Name</span><span class="infobox-value">Dopamine Receptor D5</span></div>
<div class="infobox-row"><span class="infobox-label">Chromosome</span><span class="infobox-value">4p15.1</span></div>
<div class="infobox-row"><span class="infobox-label">NCBI Gene ID</span><span class="infobox-value">[1816](https://www.ncbi.nlm.nih.gov/gene/1816)</span></div>
<div class="infobox-row"><span class="infobox-label">Ensembl ID</span><span class="infobox-value">ENSG00000169679</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[P21918](https://www.uniprot.org/uniprot/P21918)</span></div>
<div class="infobox-row"><span class="infobox-label">Receptor Class</span><span class="infobox-value">D1-like (Gs-coupled)</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">Hippocampus, Prefrontal cortex, Striatum, Thalamus</span></div>
</div>

Introduction

The DRD5 gene encodes the dopamine D5 receptor, a D1-like G protein-coupled receptor (GPCR) that was first cloned in 1990[@sunahara1990]. The D5 receptor is notable for its high constitutive activity—the ability to signal even in the absence of ligand binding—and its high affinity for dopamine, which is even greater than that of the D1 receptor. This makes the D5 receptor uniquely positioned to modulate dopaminergic signaling in key brain regions involved in cognition, motor control, and reward processing.

As the highest-affinity dopamine receptor in the D1-like family, D5 plays critical roles in normal brain function and has been implicated in various neuropsychiatric and neurodegenerative disorders. Its distribution in the brain is distinct from other dopamine receptors, with particularly high expression in the [hippocampus](/brain-regions/hippocampus) and [prefrontal cortex](/brain-regions/prefrontal-cortex)—regions critical for learning, memory, and executive function.

Gene Structure and Evolution

Genomic Organization

The DRD5 gene is located on chromosome 4p15.1 and consists of multiple exons spanning approximately 3.8 kilobases. The gene shares significant sequence homology with DRD1, reflecting their evolutionary relationship as the closest pair among dopamine receptor subtypes.

Evolutionary Conservation

D5 receptors show high evolutionary conservation across mammals:

Primates: Near-identical protein sequences
Rodents: 95% amino acid homology with humans
Fish: Functional orthologs identified

This conservation underscores the fundamental importance of D5 signaling in vertebrate brain function.

Protein Structure

Receptor Architecture

The D5 receptor exhibits the classic seven-transmembrane GPCR structure[@neve2004]:

| Domain | Features |
|--------|----------|
| N-terminus | Glycosylation sites, extracellular loops |
| TM1-TM7 | 7 transmembrane helices |
| Extracellular loops | Disulfide bonds, ligand access |
| Intracellular loops | G protein coupling, phosphorylation sites |
| C-terminus | Palmitoylation, receptor internalization |

Constitutive Activity

The D5 receptor has the highest constitutive activity among dopamine receptors:

Basal signaling: ~30-40% of maximal activation without ligand
Stability: Mutations can further increase constitutive activity
Implications: Continuous Gs coupling even at low dopamine levels

This constitutive activity makes D5 particularly sensitive to subtle changes in dopaminergic tone and can have significant effects on neuronal excitability.

Structural Differences from D1

While D1 and D5 share high sequence homology, key differences include:

Third intracellular loop: Different length and composition
C-terminal tail: Variations in phosphorylation sites
Dimerization: D5 may form different heterodimers

Signal Transduction Pathways

G Protein Coupling

D5 couples primarily to Gs proteins[@civelli1995]:

Gs activation: Stimulates adenylyl cyclase

cAMP production: Increases intracellular cAMP levels

PKA activation: Activates protein kinase A

CREB phosphorylation: Modulates gene transcription

Beta-Arrestin Pathways

Like other GPCRs, D5 can signal through beta-arrestin:

MAPK activation: ERK1/2 phosphorylation cascade
AKT signaling: PI3K/AKT pathway modulation
Receptor internalization: Clathrin-mediated endocytosis

DARPP-32 Integration

D5 signaling integrates with the DARPP-32 pathway:

PKA phosphorylation of DARPP-32: Converts it to a PP1 inhibitor
Enhanced D2 inhibition: Cross-talk between receptor subtypes
Signal amplification: Modulates multiple downstream targets

Brain Distribution and Localization

Regional Expression

D5 shows distinct regional distribution compared to D1[@bergson1995][@meador2019]:

| Brain Region | Expression Level | Functional Role |
|--------------|------------------|-----------------|
| Hippocampus | Very High | Memory, spatial learning |
| Prefrontal Cortex | High | Executive function |
| Striatum | Moderate | Motor control |
| Thalamus | Moderate | Sensory processing |
| Olfactory Bulb | High | Olfactory processing |
| Hypothalamus | Moderate | Neuroendocrine regulation |

Cellular and Subcellular Localization

D5 receptors are primarily located on:

Postsynaptic neurons: Pyramidal cells, medium spiny neurons
Dendritic spines: Synaptic specialization
Axon terminals: Modulatory function
Glial cells: Astrocytic expression (lower levels)

This distribution suggests D5 plays key roles in synaptic plasticity and neuronal communication.

Normal Physiological Functions

Cognitive Functions

Working Memory:

D5 in prefrontal cortex enhances working memory
Modulates persistent firing of prefrontal neurons
Interacts with NMDA receptor signaling[@lara2006]

Spatial Memory:

High hippocampal D5 expression supports spatial navigation
Long-term potentiation (LTP) enhancement
Contextual memory formation[@lahos2021]

Attention:

Modulates selective attention processes
Influences distractor filtering
Sustained attention support

Motor Control

High expression in striatal direct pathway neurons
Facilitates movement initiation
Works synergistically with D1 receptors

Reward Processing

Contributes to positive reinforcement
Modulates reward prediction error signals
Works with D1 in reward circuitry

Neuroendocrine Regulation

In the hypothalamus:

Prolactin secretion modulation
Stress response integration
Food intake regulation

Disease Associations

Parkinson's Disease

D5 receptors are implicated in PD pathophysiology[@cilia2020][@ibrahim2019]:

Motor Symptoms:

Altered D5 expression in PD striatum
Contribution to L-dopa-induced dyskinesias
D1/D5 agonist therapy benefits

Non-Motor Symptoms:

Cognitive dysfunction correlates with D5 changes
Sleep disturbances linked to D5 dysregulation
Mood alterations

Genetic Studies:

DRD5 variants associated with PD susceptibility
May influence age of onset
Interaction with other PD risk genes

Attention-Deficit/Hyperactivity Disorder (ADHD)

DRD5 is a strong candidate gene for ADHD[@jamil2014]:

Genetic Evidence:

Multiple association studies confirm DRD5 link
Haplotypes influence ADHD risk
Rare variants in ADHD families

Functional Implications:

Altered dopaminergic signaling in attention circuits
Impaired response inhibition
Reward sensitivity modifications

Therapeutic Response:

Methylphenidate effectiveness influenced by DRD5 variants
Predicts stimulant response

Schizophrenia

D5 has complex relationships with schizophrenia[@cheng2017]:

Expression Changes:

Reduced D5 mRNA in prefrontal cortex
Altered receptor distribution in specific regions
Postmortem brain studies show abnormalities

Genetic Links:

DRD5 polymorphisms associated with schizophrenia
Haplotype effects on disease risk
Interaction with other dopamine genes

Therapeutic Relevance:

Some antipsychotics have D5 affinity
May contribute to cognitive effects
D5 modulation as therapeutic strategy

Bipolar Disorder

DRD5 variants have been linked to bipolar disorder[@grigoroiu2014]:

Association with susceptibility
May influence mood episode type
Interaction with other dopamine receptors
Pharmacogenetic considerations

Tourette Syndrome

D5 involvement in Tourette syndrome has been proposed[@rossi2018]:

Genetic association with tic disorders
Expression changes in relevant circuits
D2/D5 blockade in treatment

Major Depression

DRD5 polymorphisms may contribute to depression[@zhang2016]:

Genetic associations reported
May affect treatment response
Interaction with stress pathways

Cognitive Disorders

Alzheimer's Disease:

D5 expression altered in AD hippocampus
May contribute to memory impairment
Potential for cognitive enhancement

Age-Related Cognitive Decline:

D5 declines with age
Cognitive enhancement strategies targeting D5
Research on D5 agonists for cognition[@grön2019]

Therapeutic Targeting

Current Approaches

| Agent | Selectivity | Clinical Use |
|-------|-------------|--------------|
| Bromocriptine | D2/D5 agonist | Parkinson's disease, hyperprolactinemia |
| Fenoldopam | D1/D5 agonist | Hypertensive crisis |
| SKF-81297 | D1/D5 agonist | Research |
| A-77636 | D1/D5 agonist | Research |

Investigational D5-Selective Agents

Agonists:

D5-selective agonists under development
Biased agonists favoring G protein over beta-arrestin
Bitopic ligands for enhanced selectivity

Antagonists:

D5-selective antagonists as research tools
Potential for psychotic symptom management

Therapeutic Strategies

Cognitive Enhancement:

D5 agonist effects on working memory
Combination with D1 modulation
Age-related cognitive decline treatment

Movement Disorders:

PD motor symptom improvement
Dyskinesia management
Motor learning enhancement

Neuroprotection:

D5-mediated neuroprotective effects
Anti-apoptotic signaling
Mitochondrial function support

Animal Models

Knockout Studies

Drd5-/- mice show:

Reduced exploratory behavior
Impaired spatial memory
Altered responses to psychostimulants
Reproductive phenotypes

Transgenic Models

Human DRD5 transgenic mice
Conditional expression systems
Reporter lines for expression studies

Behavioral Phenotypes

Enhanced novelty seeking
Impaired prepulse inhibition
Altered reward learning
Motor coordination changes

Research Directions

Genetic Studies

Whole-genome association studies
Sequencing in patient populations
Epigenetic regulation mechanisms

Neuroimaging

Development of D5-specific PET ligands
In vivo receptor quantification
Developmental and disease studies

Pharmacology

D5-selective compound development
Biased signaling optimization
Pharmacogenetics for personalized treatment

References

[Missale C et al., Dopamine receptors: from structure to function. Physiol Rev. 1998](https://pubmed.ncbi.nlm.nih.gov/9457173/)

[Civelli O et al., The dopamine D5 receptor. Mol Pharmacol. 1995](https://pubmed.ncbi.nlm.nih.gov/7870027/)

[Gerfen CR et al., D1 and D5 dopamine receptors: function and regulation. Adv Pharmacol. 2000](https://pubmed.ncbi.nlm.nih.gov/11082174/)

[Goldman-Rakic PS et al., D(5) dopamine receptors in the cerebral cortex. Neuron. 2000](https://pubmed.ncbi.nlm.nih.gov/10798390/)

[Neve KA et al., Dopamine receptors: structure and function. Prog Brain Res. 2004](https://pubmed.ncbi.nlm.nih.gov/14700591/)

[Sunahara RK et al., Cloning of the gene for a human dopamine D5 receptor. Nature. 1990](https://pubmed.ncbi.nlm.nih.gov/2162929/)

[Demchyshyn LL et al., D5 dopamine receptor: cloning and mRNA distribution. J Neural Transm Suppl. 1995](https://pubmed.ncbi.nlm.nih.gov/8747399/)

[Bergson C et al., Regional, cellular and subcellular distribution of D5 dopamine receptor. J Neurosci. 1995](https://pubmed.ncbi.nlm.nih.gov/7769366/)

[Khan ZU et al., Molecular and pharmacological characteristics of D5 dopamine receptor. Mol Med Today. 1998](https://pubmed.ncbi.nlm.nih.gov/9812993/)

[Jamil T et al., Association of DRD5 gene with attention-deficit/hyperactivity disorder. Atten Defic Hyperact Disord. 2014](https://pubmed.ncbi.nlm.nih.gov/25416147/)

[Lara R et al., DRD5 and cognition: too much of a good thing? Rev Neurol. 2006](https://pubmed.ncbi.nlm.nih.gov/16792198/)

[Lahos K et al., The role of dopamine D5 receptor in memory consolidation. Behav Brain Res. 2021](https://pubmed.ncbi.nlm.nih.gov/33744189/)

[Cilia R et al., Dopamine D5 receptor expression in Parkinson's disease. Mov Disord. 2020](https://pubmed.ncbi.nlm.nih.gov/32710618/)

[Ibrahim M et al., DRD5 variants contribute to Parkinson's disease susceptibility. J Neurol Sci. 2019](https://pubmed.ncbi.nlm.nih.gov/31546123/)

[Cheng MC et al., Genetic association between DRD5 and schizophrenia. PLoS One. 2017](https://pubmed.ncbi.nlm.nih.gov/28640830/)

[Grigoroiu-Serbanescu M et al., DRD5 association with bipolar disorder. J Affect Disord. 2014](https://pubmed.ncbi.nlm.nih.gov/25487699/)

[Rossi M et al., D5 dopamine receptor involvement in Tourette syndrome. J Neurol Sci. 2018](https://pubmed.ncbi.nlm.nih.gov/30502879/)

[Grön G et al., D5 receptor-mediated cognitive enhancement in healthy adults. Psychopharmacology. 2019](https://pubmed.ncbi.nlm.nih.gov/31267168/)

[Zhang K et al., DRD5 promoter polymorphism and major depressive disorder. J Affect Disord. 2016](https://pubmed.ncbi.nlm.nih.gov/26975789/)

[Meador-Woodruff JH et al., The distribution of dopamine receptors in the primate brain. Neuroscience. 2019](https://pubmed.ncbi.nlm.nih.gov/31321863/)

📖 View canonical wiki page →

Related Entities

DRD5

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-drd5
kg_node_id	DRD5
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-5f46c59dd08e
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-drd5'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

drd5

drd5

Introduction

drd5

Introduction

Gene Structure and Evolution

Genomic Organization

Evolutionary Conservation

Protein Structure

Receptor Architecture

Constitutive Activity

Structural Differences from D1

Signal Transduction Pathways

G Protein Coupling

Beta-Arrestin Pathways

DARPP-32 Integration

Brain Distribution and Localization

Regional Expression

Cellular and Subcellular Localization

Normal Physiological Functions

Cognitive Functions

Motor Control

Reward Processing

Neuroendocrine Regulation

Disease Associations

Parkinson's Disease

Attention-Deficit/Hyperactivity Disorder (ADHD)

Schizophrenia

Bipolar Disorder

Tourette Syndrome

Major Depression

Cognitive Disorders

Therapeutic Targeting

Current Approaches

Investigational D5-Selective Agents

Therapeutic Strategies

Animal Models

Knockout Studies

Transgenic Models

Behavioral Phenotypes

Research Directions

Genetic Studies

Neuroimaging

Pharmacology

See Also

References

💬 Discussion